Simplex Trading, LLC Neoleukin Therapeutics, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.92 - $2.25 $43,346 - $106,011	-47,116 Reduced 99.63%	176 $0
Q1 2022 May 02, 2022	BUY	$1.72 - $5.23 $75,105 - $228,373	43,666 Added 1204.25%	47,292 $88,000
Q4 2021 Feb 23, 2022	BUY	$4.65 - $7.75 $16,860 - $28,101	3,626 New	3,626 $17,000
Q2 2021 Aug 12, 2021	SELL	$9.23 - $13.12 $923 - $1,312	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$11.26 - $15.78 $5,686 - $7,968	-505 Reduced 83.47%	100 $1,000
Q4 2020 Feb 02, 2021	SELL	$10.17 - $14.56 $3,101 - $4,440	-305 Reduced 33.52%	605 $8,000
Q3 2020 Oct 14, 2020	BUY	$9.68 - $17.01 $8,808 - $15,479	910 New	910 $10,000
Q2 2020 Jul 13, 2020	SELL	$9.95 - $17.05 $8,308 - $14,236	-835 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$6.12 - $13.64 $5,110 - $11,389	835 New	835 $9,000
Q4 2019 Feb 05, 2020	SELL	$2.65 - $12.72 $2,867 - $13,763	-1,082 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$2.33 - $3.76 $2,521 - $4,068	1,082 New	1,082 $3,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.